Filtered By:
Management: WHO
This page shows you your search results in order of date. This is page number 3.
Order by Relevance | Date
Total 401 results found since Jan 2013.
Anthony Fauci: a scientific adviser's role from HIV to COVID-19
Bull World Health Organ. 2023 Jan 1;101(1):8-9. doi: 10.2471/BLT.23.030123.ABSTRACTAnthony Fauci talks to Gary Humphreys about his achievements at the National Institute of Allergy and Infectious Diseases (NIAID), his experiences advising seven consecutive United States presidents, and the challenges faced in communicating scientific evidence.PMID:36593776 | PMC:PMC9795384 | DOI:10.2471/BLT.23.030123
Source: Bulletin of the World Health Organization - January 3, 2023 Category: International Medicine & Public Health Source Type: research
Prevalence of bronchial asthma in school going children: A cross-sectional study from Uttar Pradesh
Conclusions: Asthma among school children is a public health problem in urban and rural areas. There was a rising pattern in the prevalence of asthma at national and subnational levels.
Source: Indian Journal of Public Health - November 11, 2022 Category: International Medicine & Public Health Authors: Tazeen Shamshad Najam Khalique Mohammad Shameem Mohammad Salman Shah Tabassum Nawab Source Type: research
Microplastics and Health Risks: What Do We Really Know? Microplastics and Health Risks: What Do We Really Know?
Researchers worldwide and the World Health Organization agree microplastics are everywhere and regularly ingested by all of us. Some scientists predict a major human health crisis to come.WebMD Health News
Source: Medscape Allergy Headlines - November 2, 2022 Category: Allergy & Immunology Tags: Internal Medicine News Source Type: news
Antibody weapon against malaria shows promise in Africa
A new way to prevent malaria that showed promise in 9 U.S. volunteers deliberately exposed to parasite-laden mosquitoes last year has now shown its mettle in a real-world situation in Africa. A study published today in the
New England Journal of Medicine
showed that
a single dose
of lab-produced monoclonal antibodies can protect recipients from infection for up to 6 months during Mali’s intense malaria season.
Monoclonal antibodies are expensive to produce and can be cumbersome to administer if they are infused straight into the bloodstream. That makes some researchers skeptical that the new ones to thwa...
Source: ScienceNOW - November 1, 2022 Category: Science Source Type: news
Global Tuberculosis Cases, Deaths Rise During COVID Pandemic Global Tuberculosis Cases, Deaths Rise During COVID Pandemic
This is the first time the number of tuberculosis cases and drug-resistant tuberculosis cases has gone up in a number of years, the World Health Organization said.WebMD Health News
Source: Medscape Allergy Headlines - October 28, 2022 Category: Allergy & Immunology Tags: Infectious Diseases News Source Type: news
New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders
This report will present criteria to assist the pathologist in diagnosis. Within the group of EBV-associated T and NK cell lymphomas, a new provisional entity is recognized, namely,primary nodal EBV+ T or NK cell lymphoma. The EBV + T and NK cell LPDs in children have undergone major revisions. In contrast to the 2016 WHO classification, now four major distinct groups are recognized: hydroa vacciniforme (HV) LPD, severe mosquito bite allergy, chronic active EBV (CAEBV) disease, and systemic EBV-positive T cell lymphoma of childhood. Two forms of HV LPD are recognized: the classic and the systemic forms with different epide...
Source: Virchows Archiv - October 11, 2022 Category: Pathology Source Type: research
Scientists race to test vaccines for Uganda ’s Ebola outbreak
A multipronged international effort has begun to pull out all the stops to launch trials of experimental Ebola vaccines in Uganda, which declared an outbreak of the deadly disease on 20 September. According to the most recent World Health Organization (WHO) update, Uganda has had 18 confirmed and 18 suspected cases of Ebola, including 23 deaths—an unusually high case fatality rate of 64%. A trial of a vaccine candidate that’s farthest along in development could launch before the end of next month.
Proven vaccines exist for Zaire ebolavirus, which has led to a dozen outbreaks in the neighboring Democratic Republic ...
Source: ScienceNOW - September 29, 2022 Category: Science Source Type: news
Almost everything Tucker Carlson said about Anthony Fauci this week was misleading or false
Tucker Carlson, a political commentator on Fox News, has long assailed Anthony Fauci for his role in the U.S. government’s response to the COVID-19 pandemic during both former President Donald Trump’s and President Joe Biden’s administrations. But on 22 August, when Fauci announced he would be retiring from his jobs as director of the U.S. National Institute of Allergy and Infectious Diseases (NIAID) and chief medical adviser to the president at the end of year, the
Tucker Carlson Tonight
host laid into him like never before.
Carlson asserted Fauci had committed “very serious crimes” and said he “app...
Source: ScienceNOW - August 25, 2022 Category: Science Source Type: news
A novel allergist-integrative model for vaccine allergy safety
The World Health Organization declared coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) after its initial emergence in Wuhan, China, in December 2019 and its global spread, a pandemic, on March 11, 2020. Vaccination remains the most promising strategy to end the COVID-19 pandemic. Many different public organizations and private companies worked together to make COVID-19 vaccines made available to the public. Given the novel nature of messenger RNA vaccines and initial global concerns over vaccine-related allergic reactions, worldwide health authorities took a co...
Source: Annals of Allergy, Asthma and Immunology - August 19, 2022 Category: Allergy & Immunology Authors: Ruby Pawankar, Bernard Yu-Hor Thong Tags: Editorial Source Type: research
